|
1) Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76
|
|
|
|
2) Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-72
|
|
|
|
|
|
3) Yuasa S, Fukuda K. Recent advances in cardio-vascular regenerative medicine: the induced pluripotent stem cell era. Expert Rev Cardiovasc Ther. 2008; 6: 803-10
|
|
|
|
|
|
4) Seki T, Yuasa S, Oda M, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell. 2010; 7: 11-4
|
|
|
|
|
|
5) Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med. 2010; 363: 1397-409
|
|
|
|
|
|
6) Itzhaki I, Maizels L, Huber I, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011; 471: 225-9
|
|
|
|
|
|
7) Yazawa M, Hsueh B, Jia X, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature. 2011; 471: 230-4
|
|
|
|
|
|
8) Carvajal-Vergara X, Sevilla A, DʼSouza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010; 465: 808-12
|
|
|
|
|